The drug has been shown to be effective at preventing HIV infection but does not cure an existing HIV infection.
Gilead Sciences (GILD – Research Report), the Healthcare sector company, was revisited by a Wall Street analyst yesterday. Analyst Courtney ...
"Currently, there is no therapeutic cure for HIV," Sheryl Zwerski, who holds a Doctor of Nursing Practice and directs the Prevention Sciences Program at the National Institute of Allergy and ...
Deaths from HIV/AIDS are ten times lower than at the peak of the epidemic, and new research could drive that down even more.
More than 5,000 people diagnosed with HIV each year in Argentina, with 98% of all infections a result of unprotected sex.
Graham Parry, an analyst from Bank of America Securities, maintained the Sell rating on GlaxoSmithKline (GSK – Research Report). The associated ...
A new study has revealed that daily oral antiretrovirals, like Truvada, are highly effective at preventing HIV when taken consistently alongside regular medical check-ups but their efficacy ...
Gilead is going to start testing a drug it believes could prevent HIV infection with just a single shot every year.